Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics and Tolerability of Minodronic Acid in Healthy Chinese Subjects
NCT02295436Phase 1Completed
- Start
- Aug 2014
- Primary completion
- Oct 2014
- Modality
- Small Molecules
01
Overview
Phase 1, open-label trial of minodronic acid in osteoporosis (4 arms). Primary endpoints: Maximum Plasma Concentration at 2 months and Area Under the Curve at 2 months. Started Aug 2014; status: completed.
02
Drugs
minodronic acid
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT02295436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02295436.